← Back to Screener
60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)
Price$1.84
Favorite Metrics
Price vs S&P 500 (26W)-80.22%
Price vs S&P 500 (4W)-18.21%
Market Capitalization$4.69M
All Metrics
Book Value / Share (Quarterly)$4.32
P/TBV (Annual)0.76x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-52.49%
Cash Flow / Share (Quarterly)$-6.70
Price vs S&P 500 (YTD)-16.45%
Gross Margin (TTM)42.47%
Net Profit Margin (TTM)-588.68%
EPS (TTM)$-15.22
10-Day Avg Trading Volume0.29M
EPS Excl Extra (TTM)$-15.22
EPS (Annual)$-69.93
ROI (Annual)-189.60%
Gross Margin (Annual)43.53%
Net Profit Margin (5Y Avg)-813.34%
Cash / Share (Quarterly)$4.01
Revenue Growth QoQ (YoY)256.87%
ROA (Last FY)-137.99%
Revenue Growth TTM (YoY)192.72%
EBITD / Share (TTM)$-12.11
Operating Margin (TTM)-584.65%
Cash Flow / Share (Annual)$-41.13
P/B Ratio1.06x
P/B Ratio (Quarterly)1.37x
Net Income / Employee (Annual)$-3
EV / Revenue (TTM)0.54x
Net Interest Coverage (TTM)-0.40x
ROA (TTM)-141.04%
EPS Incl Extra (Annual)$-69.93
Current Ratio (Annual)3.25x
Quick Ratio (Quarterly)2.18x
3-Month Avg Trading Volume3.14M
52-Week Price Return-85.96%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$4.17
P/S Ratio (Annual)6.89x
Asset Turnover (Annual)0.12x
52-Week High$17.68
Operating Margin (5Y Avg)-863.37%
EPS Excl Extra (Annual)$-69.93
26-Week Price Return-71.47%
Quick Ratio (Annual)2.34x
13-Week Price Return-6.81%
Total Debt / Equity (Annual)0.04x
Current Ratio (Quarterly)2.87x
Enterprise Value$0.732
Asset Turnover (TTM)0.24x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)0.85x
Pretax Margin (Annual)-1167.60%
Cash / Share (Annual)$23.90
3-Month Return Std Dev363.69%
Gross Margin (5Y Avg)25.24%
Net Income / Employee (TTM)$-3
ROE (Last FY)-196.93%
Net Interest Coverage (Annual)-32.34x
EPS Basic Excl Extra (Annual)$-69.93
Receivables Turnover (TTM)2.71x
Total Debt / Equity (Quarterly)0.03x
EPS Incl Extra (TTM)$-15.22
Receivables Turnover (Annual)1.90x
ROI (TTM)-204.09%
P/S Ratio (TTM)3.47x
Pretax Margin (5Y Avg)-817.33%
Revenue / Share (Annual)$6.00
Tangible BV / Share (Annual)$27.37
Price vs S&P 500 (52W)-121.06%
Year-to-Date Return-12.32%
5-Day Price Return-8.25%
EPS Normalized (Annual)$-69.93
ROA (5Y Avg)-216.89%
Net Profit Margin (Annual)-1166.38%
Month-to-Date Return1.71%
EBITD / Share (Annual)$-84.49
Operating Margin (Annual)-1425.84%
LT Debt / Equity (Annual)0.04x
LT Debt / Equity (Quarterly)0.03x
EPS Basic Excl Extra (TTM)$-15.22
P/TBV (Quarterly)1.42x
P/B Ratio (Annual)0.73x
Inventory Turnover (TTM)1.59x
Pretax Margin (TTM)-589.07%
Book Value / Share (Annual)$28.47
Price vs S&P 500 (13W)-9.67%
Beta3.05x
Revenue / Share (TTM)$1.47
ROE (TTM)-212.52%
52-Week Low$1.29
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.13
4.13
4.13
4.13
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
SXTP60 Degrees Pharmaceuticals, Inc. Common Stock | 3.47x | 192.72% | 42.47% | — | $1.84 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
60 Degrees Pharmaceuticals develops specialty pharmaceutical therapies for infectious diseases, including COVID-19, fungal, tick-borne, and viral infections. The company uses biological science and applied research to advance its pipeline toward commercialization.